据《金融时报》报道，阿斯利康与百时美施贵宝已举行合并谈判 (AZN:NYSE)
· seekingalpha.com
据《金融时报》报道，阿斯利康 (AstraZeneca) 和百时美施贵宝 (Bristol Myers Squibb) 已举行早期合并谈判。
AstraZeneca (AZN) and Bristol Myers Squibb (BMY) have held preliminary discussions about a potential combination that would create one of the world's largest ph...